VTVT
vTv Therapeutics Inc.
$34.63
+0.51 (+1.49%)
At close · Jul 8
Market Cap
$136.40M
Shares
3,938,895
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-29 | 2026-06-26 | |
| 8-K | 2026-05-13 | — | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| DEF 14A | 2026-04-28 | 2026-06-10 | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-02-02 | 2026-01-30 | |
| 8-K | 2025-12-19 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-09-02 | 2025-08-29 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-05-19 | — | |
| 8-K | 2025-05-16 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | 2025-06-10 | |
| 8-K | 2025-04-11 | — | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-03-17 | 2025-03-14 | |
| 8-K | 2025-02-27 | 2025-02-24 | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-25 | 2024-10-22 | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-26 | — | |
| 8-K | 2024-07-02 | 2024-06-26 | |
| 8-K | 2024-06-14 | 2024-06-11 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | 2024-06-11 | |
| 8-K | 2024-03-26 | 2024-03-25 | |
| 8-K | 2024-03-14 | 2024-03-13 | |
| 8-K | 2024-03-13 | — | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-03-05 | — | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-02-28 | 2024-02-23 | |
| 8-K | 2023-12-22 | 2023-12-18 | |
| 8-K | 2023-12-19 | 2023-12-13 |
Showing 1–50 of 132 filings